Odysight.Ai Inc. Form 8-K Summary
Business Context and Reporting Period
Odysight.Ai Inc. (Nasdaq: ODYS), a Nevada corporation, filed this Current Report on February 10, 2025. The filing announces the pricing of an initial public offering (IPO) and the company's transition from the OTCQB market to the Nasdaq Capital Market, with trading commencing on February 11, 2025.
Key Financial Metrics and Offering Details
- Offering Size: 3,307,692 shares of common stock at $6.50 per share.
- Gross Proceeds: Approximately $21.5 million.
- Net Proceeds: Approximately $18.8 million (excluding over-allotment), after deducting underwriting discounts and estimated expenses.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to 496,153 additional shares at $6.50 per share.
- Underwriting Fees: 7.0% of gross proceeds plus a 1.0% non-accountable expense allowance and up to $150,000 in reimbursable expenses.
- Use of Proceeds: Expanded research and development, increased sales and marketing, working capital, and general corporate purposes.
Note: This filing does not provide historical revenue, profit, cash flow, margin, or debt metrics for the company.
Material Changes
- Market Listing: The company ceased trading on OTCQB and commenced trading on the Nasdaq Capital Market under the symbol "ODYS".
- Capital Structure: The company entered into a definitive underwriting agreement to issue new equity, significantly increasing its capital base upon closing.
- Lock-Up Agreements: The Company, executive officers, directors, and certain 5%+ holders agreed to a 180-day lock-up period (six months for the Company) restricting the sale of shares.
Outlook, Risks, and Contingencies
- Closing Date: The offering is expected to close on or about February 12, 2025, subject to customary closing conditions.
- Forward-Looking Statements: The filing warns that the closing is not guaranteed and depends on the satisfaction of conditions and contingencies customary in underwriting agreements.
- Management Commentary: Management intends to utilize the net proceeds to accelerate R&D and sales efforts.
Investor Verification Checklist
- Confirm the final closing date of the offering (expected February 12, 2025).
- Verify the exercise of the 30-day over-allotment option by underwriters.
- Review the final prospectus for detailed risk factors and use of proceeds.
- Monitor the company's first quarterly report post-IPO for actual financial performance metrics.